一个细胞特异的计算框架揭示了泛癌缺氧特征,预测了整体生存率和ICI反应
Caiyu Zhang1, Yitong Jin2, Yifangfei Yu1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China.
The Journal of biological chemistry
|December 19, 2025
概括
这项研究引入了与缺氧相关的转录基因签名 (HYP.SIG) 来分析跨癌症的瘤缺氧. HYP.SIG可以预测免疫治疗反应和患者的存活率,识别潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 缺氧会产生一种免疫抑制的瘤微环境,有助于抗癌疗法的耐药性.
- 目前的研究缺乏泛癌缺氧的单细胞水平分析及其对免疫疗法疗效和临床结果的影响.
研究的目的:
- 使用单细胞RNA测序数据,在各种癌症类型中表征细胞特异性缺氧水平.
- 为泛癌瘤缺氧相关的转录组签名 (HYP.SIG) 开发一个计算框架.
- 评估HYP.SIG在预测免疫治疗反应,患者存活率和确定治疗点方面的实用性.
主要方法:
- 确定了细胞特异性缺氧水平,并使用38个scRNA-seq数据集 (893,464个细胞,19种癌症类型) 开发了HYP.SIG.
- 在33种癌症类型和29种正常组织 (18,901个样本) 中定义了HYP.SIG评分来表征缺氧状态.
- 使用机器学习算法和CRISPR查,建立了免疫治疗反应和整体存活率的预测模型.
主要成果:
- HYP.SIG评分显示了癌症类型与遗传不稳定性,瘤信号传递和免疫检查点抑制剂 (ICI) 治疗反应不佳的特定关联.
- 与现有的签名相比,开发的HYP.SIG实现了对ICI响应的优异预测性能.
- 综合HYP.SIG和临床阶段的预后模型准确地预测了整体存活率.
- 在缺氧驱动的瘤中确定了四个候选治疗标 (LDHA,SERF2,SLC2A1,NOP53).
结论:
- HYP.SIG提供了一种新的方法,以了解瘤缺氧在泛癌背景下.
- HYP.SIG作为一种有价值的工具,用于生存预后和预测免疫治疗反应.
- 这项研究确定了改善缺氧瘤癌症治疗策略的潜在治疗点.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K


